Skip to main content
Top

Familial Cancer

Issue 1/2024

Content (6 Articles)

Brief Report

Functional and phenotypic consequences of an unusual inversion in MSH2

Dylan Pelletier, Abhijit Rath, Nelly Sabbaghian, Manuela Pelmus, Catherine Hudon, Karine Jacob, Leora Witowski, Avi Saskin, Christopher D. Heinen, William D. Foulkes

Open Access Colorectal Cancer Original Article

Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family

James M. Chan, Mark Clendenning, Sharelle Joseland, Peter Georgeson, Khalid Mahmood, Jihoon E. Joo, Romy Walker, Julia Como, Susan Preston, Shuyi Marci Chai, Yen Lin Chu, Aaron L. Meyers, Bernard J. Pope, David Duggan, J. Lynn Fink, Finlay A. Macrae, Christophe Rosty, Ingrid M. Winship, Mark A. Jenkins, Daniel D. Buchanan

Helicobacter Pylori Short Communication

Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome

Marya Pulaski, Michaela Dungan, Marina Weber, Gillain Constantino, Bryson W. Katona

Open Access Neurofibromatosis Type 1 Original Article

Breast density in NF1 women: a retrospective study

R. De Santis, G. Cagnoli, B. Rinaldi, D. Consonni, Beatrice Conti, M. Eoli, A. Liguori, M. Cosentino, G. Carrafiello, O. Garrone, M. Giroda, C. Cesaretti, M.S. Sfondrini, D. Gambini, F. Natacci

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine